Frede Olesen. FO@alm.au.dk. Frede Olesen



Similar documents
Torben Palshof, MD, DMSci Dept. of Oncology, Aarhus University Hospital

There are many different types of cancer and sometimes cancer is diagnosed when in fact you are not suffering from the disease at all.

Follow-up care plan after treatment for breast cancer. A guide for General Practitioners

Komorbide brystkræftpatienter kan de tåle behandling? Et registerstudie baseret på Danish Breast Cancer Cooperative Group

Guideline for the Follow Up of Patients Following Treatment for Breast Cancer

Analysis of Prostate Cancer at Easter Connecticut Health Network Using Cancer Registry Data

The new Heart Failure pathway

Am I likely to develop. rheumatoid Arthritis? A guide for people with joint symptoms

OBJECTIVES By the end of this segment, the community participant will be able to:

AA Life Insurance providing access to Best Doctors. AA Life Insurance is provided by Friends Life and Pensions Limited

Appendix D- Monoclonal Gammopathy of Undetermined Significance (MGUS)

Treating Mesothelioma - A Quick Guide

Breast Cancer. Presentation by Dr Mafunga

Lung Cancer. This reference summary will help you better understand lung cancer and the treatment options that are available.

The recommendations made throughout this book are by the National Health and Medical Research Council (NHMRC).

Nurse Practitioner Role Primary Health Care In General Practice Setting.

OVARIAN CANCER TREATMENT

Knowledge develops nursing care to the benefit of patients, citizens, professionals and community

Screening for Prostate Cancer

What If I Have a Spot on My Lung? Do I Have Cancer? Patient Education Guide

Module I October 18-22, 2015 JW Marriott Marquis Hotel, Dubai, UAE

Xerox Custom Healthcare Solution

Questions to Ask My Doctor About Breast Cancer

bowel cancer screening

Chapter 15 Multiple myeloma

National Clinical Programmes

The Center for Prostate Cancer. Personalized Treatment. Clinical Excellence.

Diabetes Management in the Primary Care Setting

Neuromuscular disorders Development of consensus for diagnosis and standards of care. Thomas Sejersen, Pediatric neurology

AA Life Insurance providing access to Best Doctors. AA Life Insurance is provided by Friends Life Limited

Lung Cancer Multidisciplinary Meeting Toolkit. National Lung Cancer Working Group

Us TOO University Presents: Understanding Diagnostic Testing

Ch Medical Coding and Claims. A bill sent to the insurance carrier for payment related to patient care

Data Mining On Diabetics

Cancer research in the Midland Region the prostate and bowel cancer projects

Mobile Telecommunications in Kempten West Blood levels alarmingly altered

The End of Life Care Strategy promoting high quality care for all adults at the end of life. Prof Mike Richards July 2008

Childhood cancer in primary care from symptom to treatment. PhD dissertation. Jette Møller Ahrensberg

Medicolegal -as expert, not defendant!!

Table 16a Multiple Myeloma Average Annual Number of Cancer Cases and Age-Adjusted Incidence Rates* for

Mads Lind Ingeman 1,2,3*, Morten Bondo Christensen 1, Flemming Bro 1, Søren T. Knudsen 4 and Peter Vedsted 1,2

Inflammatory breast cancer

How To Prepare A Meeting For A Health Care Conference

The TV Series. INFORMATION TELEVISION NETWORK

Salisbury Lung Cancer Service (1 of 5)

Guide to Claims against General Practitioners (GPs)

This vision does not represent government policy but provides useful insight into how breast cancer services might develop over the next 5 years

Ovarian cancer. Patient information from the BMJ Group. What is ovarian cancer? What are the symptoms?

PRIMARY LUNG CANCER TREATMENT

What is hospice care? Answering questions about hospice care

2.1 Who first described NMO?

UICC World Cancer Congress. Cancer Staging and Quality of Care

Prostate cancer A guide for newly diagnosed men

Platinum Healthcare Plan Benefit comparison of Bronze, Silver, Gold & Platinum healthcare plans

The Effectiveness of an Outpatient Interdisciplinary Team in Reducing Distress with Lung Cancer Patients

Consultation Response Medical profiling and online medicine: the ethics of 'personalised' healthcare in a consumer age Nuffield Council on Bioethics

U.K. Familial Ovarian Cancer Screening Study (UK FOCSS) Phase 2 Patient Information Sheet

Why Service Users Say They Value Specialist Palliative Care Social Work:

How do I find the best place to get treatment for my lymphoma?

Kidney Cancer OVERVIEW

PRACTICE FRAMEWORK AND COMPETENCY STANDARDS FOR THE PROSTATE CANCER SPECIALIST NURSE

a health technology assessment Summary Danish Health Technology Assessment funded projects 2010;10(3)

Invasive lobular breast cancer

Issues Concerning Development of Products for Treatment of Non-Metastatic Castration- Resistant Prostate Cancer (NM-CRPC)

Prostate Cancer Screening

Advanced prostate cancer

Cutaneous Lymphoma FAST FACTS

Smoking and misuse of certain pain medicines can affect the risk of developing renal cell cancer.

Tumour Markers. What are Tumour Markers? How Are Tumour Markers Used?

PCA3 DETECTION TEST FOR PROSTATE CANCER DO YOU KNOW YOUR RISK OF HAVING CANCER?

1. Requirements for early detection, diagnosis and treatment. Preliminary considerations

Tubular breast cancer

It can be devastating to be diagnosed with a cancer like multiple myeloma. But there are treatments that can help you live longer and feel better.

Guidelines for Management of Renal Cancer

How To Manage A Cancer Oncology Clinic

SSNAP s Acute Organisational Audit Report 2012: Performance Summary for South London

Investigation into the death of Mr George Joseph, a prisoner at HMP Belmarsh, in April 2015

Early Prostate Cancer: Questions and Answers. Key Points

Community health care services Alternatives to acute admission & Facilitated discharge options. Directory

Transcription:

Professor, DrMedSc, GP, FRCGP(hon.) The Research Unit for General Practice, Aarhus University Chairman of the board of The Danish Cancer Society FO@alm.au.dk

The pathway to better results Support to realtives Terminal care Palliation Follow up, recurrence Treatment Rehabilitation Confirmed detailed diagnosis Primary diagnostic procedures, waits, available service Symptoms which symptoms predictive value Crisis Perceived symptoms, treshold for contact to Gen. Practice Screene Need for GP Lifestyle, health promotion, prevention

The disease journey Today s focus Palliation Support to realtives Terminal care Follow up, recurrence Treatment Rehabilitation Confirmed detailed diagnosis Primary diagnostic procedures, waits, available service Symptoms which symptoms predictive value Crisis Perceived symptoms, treshold for contact to Gen. Practice Screene Need for GP Lifestyle, health promotion, prevention

Waits are unacceptable: Cancer as an acute disease the 3-point strategy from the Danish Cancer Society in 2007 1: Improved acces to relevant diagnostic investigations without waits when required by the front line care in a heath care system (general practice) Reduce double gatekeeping 2: Diagnostic centres at all major hospitals Multidisciplinary acute assessment by specialists without waits A patient can be referred with the diagnosis: I suspect serious disease, but I do not know which disease cancer is a possibility 3: Fast track clinical pathways when a specific cancer is considered The fast track packages have been developed by multidisciplinary cancer groups in a process led by the National Board of Health Regional multidisciplinary cancer groups implement the strategy FROM 2007 MASSIVE POLITICAL AND MANAGEMENT FOCUS ON CANCER AS AN ACUTE DISEASE

Waits are unacceptable: Cancer as an acute disease the 3-point strategy from the Danish Cancer Society in 2007 1: Improved acces to relevant diagnostic investigations without waits when required by the front line care in a heath care system (general practice) Reduce double gatekeeping 2: Diagnostic centres at all major hospitals Multidisciplinary acute assessment by specialists without waits A patient can be referred with the diagnosis: I suspect serious disease, but I do not know which disease cancer is a possibility 3: Fast track clinical pathways when a specific cancer is considered The fast track packages have been developed by multidisciplinary cancer groups in a process led by the National Board of Health Regional multidisciplinary cancer groups implement the strategy

Waits are unacceptable: Cancer as an acute disease the 3-point strategy from the Danish Cancer Society in 2007 1: Improved acces to relevant diagnostic investigations without waits when required by the front line care in a heath care system (general practice) Reduce double gatekeeping 2: Diagnostic centres at all major hospitals Multidisciplinary acute assessment by specialists without waits A patient can be referred with the diagnosis: I suspect serious disease, but I do not know which disease cancer is a possibility 3: Fast track clinical pathways when a specific cancer is considered The fast track packages have been developed by multidisciplinary cancer groups in a process led by the National Board of Health Regional multidisciplinary cancer groups implement the strategy

Worldwide: we all appreciate the good sides of fast track pathway packages for serious disease But: it is dangerous as the only approach to first line diagnostics! The problem: can only be used, when cancer is very likely

Why did the Danish Cancer Society demand the 3-step strategy

Diagnostic scan Progression in tumor-size, but stage unchanged (T4) Treatment planning scan A patient with 19 days between scans. Note the bone destruction AR Jensen et al. Radiother Oncol 2007

Diagnostic scan Progression in N-site, but stage unchanged (N3) Treatment planning scan A patient with 47 days in between scans. Note growth of the lymph node metastasis and appearance of a contralaterale metastasis AR Jensen et al. Radiother Oncol 2007

Time intervals and milestones in early diagnosis Diagnostic delay Weller, Vedsted, Rubin G, et al. The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br J Cancer. 2012;106:1262-7. doi:10.1038/bjc.2012.68

System-related delay before 2007 - or whether the system reacts appropriately? Delay in days 0 100 200 300 400 25% percentile: 32 days Median: 55 days 75% percentile: 93 days 0 500 1000 1500 Patients Delay > 1 year = 365 days Rikke Pilegaard Hansen. PhD. 2008; Aarhus University

When do we classify cancer stage? Danish patients are diagnosed in a later stage One of the most frequent statements made, but we do not know if it is true If you make health care planning based on this assumption you may make great mistakes The blind spot is the length of the clinical pathway Danish patients are in a later stage, when treatment starts!!! This may be due to late presentation, late suspicion of cancer and a slow clinical pathway within the health care system To which extent does a slow clinical pathway influence prognosis?

The missing link in the diagnosis of serious disease What do we know about the journey from first symptom to start of the specific tratment? Can we improve and shorten the diagnostic proces? A major hitherto neglected research focus The Danish Cancer Society and the Novo Nordic Foundation have initiated and funded this reseach including the Research Centre for early diagnosis of cancer i Aarhus the CaP centre led by Prof. Peter Vedsted Silkeborg and Vejle Hospitals led the development of new thinking about organisation of the diagnostic process within the hospital A special focus on service in the first line diagnostic process

Positive predictive value of alarm symtoms in GP - a GP must investigate or refer between 13 and 50 patients to find one cancer in patients with alarm symptoms Blood in the urine Difficulty in swallowing Blood in sputum Men Women N Cancer PPV 3 year Cancer PPV 3year 11.108 472 7,4% 162 3,4% 5.999 150 5,7% 81 2,4% 4.812 220 7,5% 81 4,3% Blood in stools 15.289 184 2,4% 154 2,0% Jones R et al. BMJ 2007;334;1040

Total delay (mean) 0 50 100 150 200 Patient, Fordeling doctor af and patient, system læge delay og system in a cohort delay - Only 50% present with obvious signs of cancer Alarm 49,7% 49.7% Almen 23.9% Ukarakteristisk 26.4% Lægens svar vedr. symptomtolkning General 23,9 % Non char. symptoms 26,4% Patientdelay Systemdelay Prim Doctor Lægedelay PHC Systemdelay Sec

Total delay (mean) 0 50 100 150 200 Patient, Fordeling doctor af and patient, system læge delay og system in a cohort delay - Only 50% present with obvious signs of cancer Alarm 49,7% 49.7% Almen 23.9% Ukarakteristisk 26.4% Lægens svar vedr. symptomtolkning General 23,9 % Non char. symptoms 26,4% Patientdelay Systemdelay Prim Doctor Lægedelay PHC Systemdelay Sec

E.g. Presenting symptoms in 1900 consecutive newly diagnosed cancer patients Nielsen, Hansen, Vedsted. Ugeskr Læger. 2010;172:2827-31

Total delay (mean) 0 50 100 150 200 Patient, Fordeling doctor af and patient, system læge delay og system in a cohort delay - Only 50% present with obvious signs of cancer Alarm 49,7% 49.7% Almen 23.9% Ukarakteristisk 26.4% Lægens svar vedr. symptomtolkning General 23,9 % Non char. symptoms 26,4% Patientdelay Systemdelay Prim Doctor Lægedelay PHC Systemdelay Sec

Total delay (mean) 0 50 100 150 200 Patient, Fordeling doctor af and patient, system læge delay og system in a cohort delay - Only 50% present with obvious signs of cancer Alarm 49,7% 49.7% Almen 23.9% Ukarakteristisk 26.4% Lægens svar vedr. symptomtolkning General 23,9 % Non char. symptoms 26,4% Patientdelay Systemdelay Prim Doctor Lægedelay PHC Systemdelay Sec

Total delay (mean) 0 50 100 150 200 Patient, Fordeling doctor af and patient, system læge delay og system in a cohort delay - Only 50% present with obvious signs of cancer Alarm 49,7% 49.7% Almen 23.9% Ukarakteristisk 26.4% Lægens svar vedr. symptomtolkning General 23,9 % Non char. symptoms 26,4% Patientdelay Systemdelay Prim Doctor Lægedelay PHC Systemdelay Sec

Total delay (mean) 0 50 100 150 200 Patient, Fordeling doctor af and patient, system læge delay og system in a cohort delay - Only 50% present with obvious signs of cancer Alarm 49,7% 49.7% Almen 23.9% Ukarakteristisk 26.4% Lægens svar vedr. symptomtolkning General 23,9 % Non char. symptoms 26,4% Patientdelay Systemdelay Prim Doctor Lægedelay PHC Systemdelay Sec

A wrong way of analysing data Dødsrisiko efter 3år Ventetid uger

A slow diagnostic process influences prognosis - a UK estimate: 5-10.000 lives/year -in Denmark with 5.5 mill. inhab.: 500 1000/year

The 3-step model for improvement If it is simple : Access to quick and correct diagnostic tests If it is difficult: Access to comprehensive diagnostic service If we think we know: The fast track package, when we know the way forward

Let us share our experiences and learn more

Total delay (mean) 0 50 100 150 200 Patient, Fordeling doctor af and patient, system læge delay og system in a cohort delay - Only 50% present with obvious signs of cancer The focus for this conference Alarm 49,7% 49.7% Almen 23.9% Ukarakteristisk 26.4% Lægens svar vedr. symptomtolkning General 23,9 % Non char. symptoms 26,4% Patientdelay Systemdelay Prim Doctor Lægedelay PHC Systemdelay Sec

The cancer journey Todays focus Palliation Support to realtives Terminal care Follow up, recurrence Treatment Rehabilitation Confirmed detailed diagnosis Primary diagnostic procedures, waits, available service Symptoms which symptoms predictive value Crisis Perceived symptoms, treshold for contact to Gen. Practice Screene Need for GP Lifestyle, health promotion, prevention

The hospital as service provider to general practice in a comprehensive seamless health care system

The ultimate aim: a better general approach to appropriate and quick diagnosis in a health care system. A large locomotive for general improvements in early diagnosis of serious disease